WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted ...
Genentech unit have become the latest drugmakers to offer their medicines on TrumpRx, a government-run direct-to-consumer ...
Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...
Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...
California-based Genentech plans to create up 420 jobs in Holly Springs -- a deal expected to bring an investment of up to $700 million, state officials said Monday. Gov. Josh Stein is expected to ...
- Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment - - Phase III studies for fenebrutinib in ...
– Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, in a post-CDK inhibitor setting, compared with ...
WASHINGTON, March 25, 2026 /PRNewswire/ -- The Lupus Foundation of America proudly announced that Genentech, a member of the Roche Group, will serve as this year's presenting sponsor of the Walk to ...
Over the past day, Genentech has been making a concerted bid to expand its partnered portfolio into the hottest R&D areas. Only hours after the Roche unit signed a radiopharmaceutical-focused pact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results